A nonrandomized, open-label study to evaluate the effect of nasal stimulation on tear production in subjects with dry eye disease

scientific article published on 4 May 2016

A nonrandomized, open-label study to evaluate the effect of nasal stimulation on tear production in subjects with dry eye disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2147/OPTH.S101716
P932PMC publication ID4862385
P698PubMed publication ID27217719

P2093author name stringArturo Chayet
James Loudin
Karla Butron
Neil J Friedman
Nora Robledo
Stephanie N Baba
P2860cites workLong-term retention rates and complications of silicone punctal plugs in dry eye.Q50955676
Nasolacrimal stimulation of aqueous tear production.Q51533385
The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample.Q51934443
Utility assessment among patients with dry eye disease.Q53379868
Ophthalmologist Perceptions Regarding Treatment of Moderate-to-Severe Dry Eye: Results of a Physician SurveyQ61759590
The detection of bacteria and bacterial biofilms in punctal plug holesQ73828857
Dry eye: prevalence, utilization, and economic implicationsQ75260269
The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)Q80347907
Prevalence of dry eye syndrome among US womenQ28196875
Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseasesQ28241769
Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studiesQ28360278
Neuromodulation: present and emerging methodsQ30434028
Drug discovery: a jump-start for electroceuticalsQ34338746
The aging lacrimal gland: changes in structure and function.Q34385610
New horizons in neuromodulationQ34402634
Neurostimulation of the lacrimal nerve for enhanced tear productionQ35085293
Corneal nerves: structure, contents and functionQ35107870
Impact of dry eye syndrome on vision-related quality of lifeQ35741609
Dry eye: diagnosis and current treatment strategiesQ35790953
Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye diseaseQ35907009
Dysfunctional tear syndrome: a Delphi approach to treatment recommendationsQ36653052
Lodged intracanalicular plugs as a cause of lacrimal obstructionQ36783051
Dry eye disease: an immune-mediated ocular surface disorderQ36916372
Neuromodulation for brain disorders: challenges and opportunitiesQ37046939
Choice of artificial tear formulation for patients with dry eye: where do we start?Q38049525
Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meetingQ38151227
Deep brain stimulation: how does it work?Q38151312
Electrical and mechanical office-based neuromodulationQ38158669
Peripheral neuromodulation: a reviewQ38199628
Efficacy and retention rate of two types of silicone punctal plugs in patients with and without Sjögren syndromeQ44845083
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjecteye diseaseQ3041498
P304page(s)795-804
P577publication date2016-05-04
P1433published inClinical OphthalmologyQ5133782
P1476titleA nonrandomized, open-label study to evaluate the effect of nasal stimulation on tear production in subjects with dry eye disease
P478volume10

Reverse relations

cites work (P2860)
Q91906669A comparative study of the quality of non-stimulated and stimulated tears in normal eye male subjects using the tear ferning test
Q92442286Advances in dry eye disease treatment
Q39404635Dry Eye Management: Targeting the Ocular Surface Microenvironment.
Q36252489Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment
Q33585580Enhanced Tearing by Electrical Stimulation of the Anterior Ethmoid Nerve
Q52889830Randomized Controlled Crossover Trial Comparing the Impact of Sham or Intranasal Tear Neurostimulation on Conjunctival Goblet Cell Degranulation.
Q50039889[Novel current and future therapy options for treatment of dry eye disease].

Search more.